Metabolic role of lactobacilli in weight modification in humans and animals

Microbial Pathogenesis

Volumn 106, Issue , 2017, Pages 182-194

  Drissi, Fatima ^a   Raoult, Didier ^a   Merhej, Vicky ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Bacteriocin; Carbohydrate; Lactobacillus; Lipid; Microbiota; Probiotic; Weight gain; Weight loss

Indexed keywords

BACTERIAL GENOME; BACTEROIDETES; BODY MASS; BODY WEIGHT; CARBOHYDRATE METABOLISM; COLONY FORMING UNIT; COMORBIDITY; DIGESTION; FIRMICUTES; GASTROINTESTINAL TRACT; HUMAN; INTESTINE FLORA; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS AGILIS; LACTOBACILLUS FERMENTUM; LACTOBACILLUS GASSERI; LACTOBACILLUS INGLUVIEI; LACTOBACILLUS PLANTARUM; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; LACTOBACILLUS SAKEI; LACTOBACILLUS SALVARIUS; LIPID DEGRADATION; LIPOGENESIS; METABOLIC REGULATION; NONHUMAN; POPULATION DENSITY; REVIEW; WEIGHT CHANGE; WEIGHT GAIN; ANIMAL; BACTERIUM; BILE; CELL PROLIFERATION; COLON; DRUG EFFECTS; DUODENUM; JEJUNUM; LIPID METABOLISM; METABOLISM; METABOLOME; MICROBIOLOGY; OBESITY; PH; PHYSIOLOGY; PUBLIC HEALTH; SPECIES DIFFERENCE; WEIGHT REDUCTION;

ANTIINFECTIVE AGENT; BACTERIOCIN; PROBIOTIC AGENT;

ANIMALS; ANTI-INFECTIVE AGENTS; BACTERIA; BACTERIOCINS; BILE; BODY WEIGHT; CARBOHYDRATE METABOLISM; CELL PROLIFERATION; COLON; DIGESTION; DUODENUM; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; HYDROGEN-ION CONCENTRATION; JEJUNUM; LACTOBACILLUS; LIPID METABOLISM; METABOLOME; OBESITY; PROBIOTICS; PUBLIC HEALTH; SPECIES SPECIFICITY; WEIGHT GAIN; WEIGHT LOSS;

EID: 84962110190     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2016.03.006     Document Type: Review

References (180)

1. [1] Kahn, Steven E., Hull, Rebecca L., Utzschneider, Kristina M., Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:7121 (2006), 840–846.
2. [2] Carmiel-Haggai, M., Cederbaum, A.I., Nieto, N., A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats. FASEB J. 19:1 (2005), 136–138.
3. [3] Drewnowski, A., Obesity, diets, and social inequalities. Nutr. Rev. 67:Suppl. 1 (2009 May), S36–S39, 10.1111/j.1753-4887.2009.00157.x Review.
4. [4] Ley, R.E., Backhed, F., Turnbaugh, P., Lozupone, C.A., Knight, R.D., Gordon, J.I., Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. U. S. A. 102:31 (2005 Aug 2), 11070–11075.
5. [5] Ley, R.E., Turnbaugh, P.J., Klein, S., Gordon, J.I., Microbial ecology: human gut microbes associated with obesity. Nature 444:7122 (2006), 1022–1023.
6. [6] Turnbaugh, P.J., Backhed, F., Fulton, L., Gordon, J.I., Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3:4 (2008 Apr 17), 213–223.
7. [7] Armougom, F., Henry, M., Vialettes, B., et al. Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and methanogens in anorexic patients. PLoS One, 4, 2009 e7125.
8. [8] Million, M., Angelakis, E., Paul, M., Armougom, F., Leibovici, L., Raoult, D., Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals. Microb. Pathog. 53:2 (2012 Aug), 100–108.
9. [9] Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R., Gordon, J.I., An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444:7122 (2006 Dec 21), 1027–1031.
10. [10] Backhed, F., Ding, H., Wang, T., Hooper, L.V., Koh, G.Y., Nagy, A., et al. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. U. S. A. 101:44 (2004 Nov 2), 15718–15723.
11. [11] Lee, K., Paek, K., Lee, H.Y., Park, J.H., Lee, Y., Antiobesity effect of trans-10,cis-12-conjugated linoleic acid-producing Lactobacillus plantarum PL62 on diet-induced obese mice. J. Appl. Microbiol. 103:4 (2007 Oct), 1140–1146.
12. [12] Cani, P.D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58:8 (2009 Aug), 1091–1103.
13. [13] Frazier, T.H., DiBaise, J.K., McClain, C.J., Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury. JPEN J. Parenter. Enter. Nutr. 35:Suppl. 5 (2011 Sep), 14S–20S.
14. [14] Molly, K., De Smet, I., Nollet, L., Van de Woestyne, M., Verstraet, W., Effect of lactobacilli on the ecology of the gastro-intestinal microbiota cultured in the SHIME reactor. Microb. Ecol. Health Dis. 9 (1996), 79–89.
15. [15] Slover, C.M., Danziger, L., Lactobacillus: a review. Clin. Microbiol. Newsl. 30:4 (15 February 2008), 23–27.
16. [16] Riboulet-Bisson, E., Sturme, M.H., Jeffery, I.B., O'Donnell, M.M., Neville, B.A., Forde, B.M., et al. Effect of Lactobacillus salivarius bacteriocin Abp118 on the mouse and pig intestinal microbiota. PLoS One, 7(2), 2012, e31113.
17. [17] Miyoshi, M., Ogawa, A., Higurashi, S., Kadooka, Y., Anti-obesity effect of Lactobacillus gasseri SBT2055 accompanied by inhibition of pro-inflammatory gene expression in the visceral adipose tissue in diet-induced obese mice. Eur. J. Nutr. 53:2 (2014 Mar), 599–606.
18. [18] Rodes, L., Khan, A., Paul, A., Coussa-Charley, M., Marinescu, D., Tomaro-Duchesneau, C., et al. Effect of probiotics Lactobacillus and Bifidobacterium on gut-derived lipopolysaccharides and inflammatory cytokines: an in vitro study using a human colonic microbiota model. J. Microbiol. Biotechnol. 23:4 (2013 Apr), 518–526.
19. [19] Santos, R.C., Lakhdari, O., Blottiere, H.M., Blugeon, S., Sokol, H., Bermudez-Humaran, L.G., et al. Anti-inflammatory properties of dairy lactobacilli. Inflamm. Bowel Dis. 18:4 (2012 Apr), 657–666.
20. [20] Diaz-Ropero, M.P., Martin, R., Sierra, S., Lara-Villoslada, F., Rodriguez, J.M., Xaus, J., et al. Two Lactobacillus strains, isolated from breast milk, differently modulate the immune response. J. Appl. Microbiol. 102:2 (2007 Feb), 337–343.
21. [21] Angelakis, E., Bastelica, D., Ben, A.A., El, F.A., Dutour, A., Mege, J.L., et al. An evaluation of the effects of Lactobacillus ingluviei on body weight, the intestinal microbiome and metabolism in mice. Microb. Pathog. 52:1 (2012 Jan), 61–68.
22. [22] Angelakis, E., Armougom, F., Million, M., Raoult, D., The relationship between gut microbiota and weight gain in humans. Future Microbiol. 7 (2012), 91–109.
23. [23] Caplice, E., Fitzgerald, G.F., Food fermentations: role of microorganisms in food production and preservation. Int. J. Food Microbiol. 50:1–2 (1999 Sep 15), 131–149.
24. [24] Leroy, F., De Vuyst, L., Lactic acid bacteria as functional starter cultures for the food fermentation industry. Trends Food Sci. Technol. 15:2 (2004), 67–78.
25. [25] Million, M., Lagier, J.C., Yahav, D., Paul, M., Gut bacterial microbiota and obesity. Clin. Microbiol. Infect. 19:4 (2013 Apr), 305–313.
26. [26] Yatsunenko, T., Rey, F.E., Manary, M.J., Trehan, I., Dominguez-Bello, M.G., Contreras, M., Magris, M., Hidalgo, G., Baldassano, R.N., Anokhin, A.P., Heath, A.C., Warner, B., Reeder, J., Kuczynski, J., Caporaso, J.G., Lozupone, C.A., Lauber, C., Clemente, J.C., Knights, D., Knight, R., Gordon, J.I., Human gut microbiome viewed across age and geography. Nature 486:7402 (2012 May 9), 222–227.
27. [27] Guarner, F., Malagelada, J.R., Gut flora in health and disease. Lancet 361:9356 (2003 Feb 8), 512–519.
28. [28] Booijink, C.C., Zoetendal, E.G., Kleerebezem, M., de Vos, W.M., Microbial communities in the human small intestine: coupling diversity to metagenomics. Future Microbiol. 2:3 (2007 Jun), 285–295.
29. [29] Maukonen, J., Motto, J., Suihko, M.L., Saarela, M., Intra-individual diversity and similarity of salivary and faecal microbiota. J. Med. Microbiol. 57 (2008), 1560–1568.
30. [30] Shanahan, F., The colonic microbiota and colonic disease. Curr. Gastroenterol. Rep. 14:5 (2012 Oct), 446–452, 10.1007/s11894-012-0281-5.
31. [31] Gerritsen, J., Smidt, H., Rijkers, G.T., de Vos, W.M., Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr. 6 (2011), 209–240.
32. [32] Nam, Y.D., Jung, M.J., Roh, S.W., Kim, M.S., Bae, J.W., Comparative analysis of Korean human gut microbiota by barcoded pyrosequencing. PLoS One, 6(7), 2011, e22109.
33. [33] Eckburg, P.B., Bik, E.M., Bernstein, C.N., Purdom, E., Dethlefsen, L., et al. Diversity of the human intestinal microbial flora. Science 308 (2005), 1635–1638.
34. [34] Turnbaugh, P.J., Hamady, M., Yatsunenko, T., Cantarel, B.L., Duncan, A., Ley, R.E., Sogin, M.L., Jones, W.J., Roe, B.A., Affourtit, J.P., Egholm, M., Henrissat, B., Heath, A.C., Knight, R., Gordon, J.I., A core gut microbiome in obese and lean twins. Nature 457:7228 (2009), 480–484.
35. [35] Bervoets, L., Van, H.K., Kortleven, I., Van, N.C., Hens, N., Vael, C., et al. Differences in gut microbiota composition between obese and lean children: a cross-sectional study. Gut Pathog., 5(1), 2013, 10.
36. [36] Million, M., Angelakis, E., Maraninchi, M., Henry, M., Giorgi, R., Valero, R., Vialettes, B., Raoult, D., Correlation between body mass index and gut concentrations of Lactobacillus reuteri, Bifidobacterium animalis, Methanobrevibacter smithii and Escherichia coli. Int. J. Obes. (Lond) 37:11 (2013 Nov), 1460–1466.
37. [37] Karlsson, F.H., Tremaroli, V., Nookaew, I., Bergström, G., Behre, C.J., Fagerberg, B., Nielsen, J., Bäckhed, F., Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498:7452 (2013 Jun 6), 99–103.
38. [38] Kalliomaki, M., Collado, M.C., Salminen, S., Isolauri, E., Early differences in fecal microbiota composition in children may predict overweight. Am. J. Clin. Nutr. 87:3 (2008 Mar), 534–538.
39. [39] Angelakis, E., Raoult, D., The increase of Lactobacillus species in the gut flora of newborn broiler chicks and ducks is associated with weight gain. PLoS One, 5(5), 2010, e10463.
40. [40] Musso, G., Gambino, R., Cassader, M., Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded?. Diabetes Care 33:10 (2010 Oct), 2277–2284.
41. [41] Ridaura, V.K., Faith, J.J., Rey, F.E., Cheng, J., Duncan, A.E., Kau, A.L., et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science, 341(6150), 2013 Sep 6, 1241214.
42. [42] Fåk, F., Bäckhed, F., Lactobacillus reuteri prevents diet-induced obesity, but not atherosclerosis, in a strain dependent fashion in Apoe-/- mice. PLoS One, 7(10), 2012, e46837.
43. [43] Ji, Y.S., Kim, H.N., Park, H.J., Lee, J.E., Yeo, S.Y., Yang, J.S., et al. Modulation of the murine microbiome with a concomitant anti-obesity effect by Lactobacillus rhamnosus GG and Lactobacillus sakei NR28. Benef. Microbes 3:1 (2012 Mar 1), 13–22.
44. [44] Stsepetova, J., Sepp, E., Kolk, H., Loivukene, K., Songisepp, E., Mikelsaar, M., Diversity and metabolic impact of intestinal Lactobacillus species in healthy adults and the elderly. Br. J. Nutr. 105:8 (2011 Apr), 1235–1244.
45. [45] Capcarova, M., Weiss, J., Hrncar, C., Kolesarova, A., Pal, G., Effect of Lactobacillus fermentum and Enterococcus faecium strains on internal milieu, antioxidant status and body weight of broiler chickens. J. Anim. Physiol. Anim. Nutr. Berl. 94:5 (2010 Oct), e215–e224.
46. [46] Omar, J.M., Chan, Y.M., Jones, M.L., Prakash, S., Jones, P.J.H., Lactobacillus fermentum and Lactobacillus amylovorus as probiotics alter body adiposity and gut microflora in healthy persons. J. Funct. Foods 5:1 (2013 Jan), 116–123.
47. [47] Vendt, N., Grunberg, H., Tuure, T., Malminiemi, O., Wuolijoki, E., Tillmann, V., et al. Growth during the first 6 months of life in infants using formula enriched with Lactobacillus rhamnosus GG: double-blind, randomized trial. J. Hum. Nutr. Diet. 19:1 (2006 Feb), 51–58.
48. [48] Lee, H.Y., Park, J.H., Seok, S.H., Baek, M.W., Kim, D.J., Lee, K.E., Paek, K.S., Lee, Y., Park, J.H., Human originated bacteria, Lactobacillus rhamnosus PL60, produce conjugated linoleic acid and show anti-obesity effects in diet-induced obese mice. Biochim. Biophys. Acta 1761:7 (2006 Jul), 736–744.
49. [49] Hu, X., Wang, T., Li, W., Jin, F., Wang, L., Effects of NS Lactobacillus strains on lipid metabolism of rats fed a high-cholesterol diet. Lipids Health Dis., 12, 2013, 67.
50. [50] Sato, K., Takahashi, K., Tohno, M., Miura, Y., Kamada, T., Ikegami, S., et al. Immunomodulation in gut-associated lymphoid tissue of neonatal chicks by immunobiotic diets. Poult. Sci. 88:12 (2009 Dec), 2532–2538.
51. [51] FAO/WHO, Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. 2001, Joint FAO/WHO Expert Consultation, Food and Agriculture Organisation of the United Nations, Cordoba, Argentina.
52. [52] Anadon, A., Martínez-Larranaga, M.R., Caballero, V., Probiotics for animal nutrition: regulation and safety assessment. Pérez, Guerra N., Pastrana, Castro L., (eds.) Probiotics: Production, Evaluation and Uses in Animal Feed, 2010, Research Signpost, Kerela, 1–14.
53. [53] Fuller, R., Probiotics for farm animals. Tannock, G.W., (eds.) Probiotics: a Critical Review, 1999, Garland Science, New York, NY, 15–22.
54. [54] Tuohy, K.M., Probert, H.M., Smejkal, C.W., Gibson, G.R., Using probiotics and prebioticsto improve gut health. Drug Discov. Today 8:15 (2003 Aug 1), 692–700.
55. [55] Alvarez-Olmos, M.I., Oberhelman, R.A., Probiotic agents and infectious diseases: a modern perspective on a traditional therapy. Clin. Infect. Dis. 32 (2001), 1567–1576.
56. [56] Viljanen, M., Kuitunen, M., Haahtela, T., Juntunen-Backman, K., Korpela, R., Savilahti, E., Probiotic effects on faecal inflammatory markers and on faecal IgA in food allergic atopic eczema/dermatitis syndrome infants. Pediatr. Allergy Immunol. 16:1 (2005 Feb), 65–71.
57. [57] Bongaerts, G.P., Severijnen, R.S., Preventive and curative effects of probiotics in atopic patients. Med. Hypotheses 64:6 (2005), 1089–1092.
58. [58] Chau, K., Lau, E., Greenberg, S., Jacobson, S., Yazdani-Brojeni, P., Verma, N., Koren, G., Probiotics for infantile colic: a randomized, double-blind, placebo-controlled trial investigating Lactobacillus reuteri DSM 17938. J. Pediatr. 166:1 (2015 Jan), 74–78.
59. [59] Racedo, S., Villena, J., Medina, M., Agüero, G., Rodríguez, V., Alvarez, S., Lactobacillus casei administration reduces lung injuries in a Streptococcus pneumonia infection in mice. Microbes Infect. 8:9–10 (2006 Aug), 2359–2366.
60. [60] Niedzielin, K., Kordecki, H., Birkenfeld, B., A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur. J. Gastroenterol. Hepatol. 13:10 (2001 Oct), 1143–1147.
61. [61] Reid, G., Bruce, A.W., Fraser, N., Heinemann, C., Owen, J., Henning, B., Oral probiotics can resolve urogenital infections. FEMS Immunol. Med. Microbiol. 30 (2001), 49–52.
62. [62] Venturi, A., Gionchetti, P., Rizzello, F., Johansson, R., Zucconi, E., Brigidi, P., Matteuzzi, D., Campieri, M., Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Aliment. Pharmacol. Ther. 13:8 (1999 Aug), 1103–1108.
63. [63] Sakamoto, I., Igarashi, M., Kimura, K., Takagi, A., Miwa, T., Koga, Y., Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans. J. Antimicrob. Chemother. 47:5 (2001 May), 709–710.
64. [64] Hamilton-Miller, J.M., The role of probiotics in the treatment and prevention of Helicobacter pylori infection. Int. J. Antimicrob. Agents 22:4 (2003 Oct), 360–366.
65. [65] Marelli, G., Papaleo, E., Ferrari, A., Lactobacilli for prevention of urogenital infections: a review. Eur. Rev. Med. Pharmacol. Sci. 8:2 (2004 Mar-Apr), 87–95.
66. [66] Merk, K., Borelli, C., Korting, H.C., Lactobacilli - bacteria-host interactions with special regard to the urogenital tract. Int. J. Med. Microbiol. 295:1 (2005 Apr), 9–18.
67. [67] Roller, M., Pietro Femia, A., Caderni, G., Rechkemmer, G., Watzl, B., Intestinal immunity of rats with colon cancer is modulated by oligofructose-enriched inulin combined with Lactobacillus rhamnosus and Bifidobacterium lactis. Br. J. Nutr. 92:6 (2004 Dec), 931–938.
68. [68] Sazawal, S., Hiremath, G., Dhingra, U., Malik, P., Deb, S., Black, R.E., Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect. Dis. 6:6 (2006 Jun), 374–382.
69. [69] Angelakis, E., Merhej, V., Raoult, D., Related actions of probiotics and antibiotics on gut microbiota and weight modification. Lancet Infect. Dis. 13:10 (2013 Oct), 889–899.
70. [70] Dunne, C., O'Mahony, L., Murphy, L., Thornton, G., Morrissey, D., O'Halloran, S., Feeney, M., Flynn, S., Fitzgerald, G., Daly, C., Kiely, B., O'Sullivan, G.C., Shanahan, F., Collins, J.K., In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. Am. J. Clin. Nutr. 73:Suppl. 2 (2001 Feb), 386S–392S.
71. [71] Zilberstein, B., Quintanilha, A.G., Santos, M.A., Pajecki, D., Moura, E.G., Alves, P.R., et al. Digestive tract microbiota in healthy volunteers. Clin. (Sao Paulo) 62:1 (2007 Feb), 47–54.
72. [72] Tannock, G.W., A special fondness for Lactobacilli. Appl. Environ. Microbiol. 70:6 (2004), 3189–3194, 10.1128/AEM.70.6.3189-3194.2004.
73. [73] Shi, Y., Burn, P., Lipid metabolic enzymes: emerging drug targets for the treatment of obesity. Nat. Rev. Drug Discov. 3:8 (2004 Aug), 695–710.
74. [74] Whitcomb, D.C., Lowe, M.E., Human pancreatic digestive enzymes. Dig. Dis. Sci. 52:1 (2007 Jan), 1–17 Epub 2007 Jan 5.
75. [75] Kaoutari, El, Armougom, F., Gordon, J.I., Raoult, D., Henrissat, B., The abundance and variety of carbohydrate-active enzymes in the human gut microbiota. Nat. Rev. Microbiol. 11:7 (2013 Jul), 497–504.
76. [76] Cantarel, B.L., Lombard, V., Henrissat, B., Complex carbohydrate utilization by the healthy human microbiome. PLoS One, 7, 2012, e28742.
77. [77] Wang, Z., Zeng, X., Mo, Y., Smith, K., Guo, Y., Lin, J., Identification and characterization of a bile salt hydrolase from Lactobacillus salivarius for development of novel alternatives to antibiotic growth promoters. Appl. Environ. Microbiol. 78:24 (2012 Dec), 8795–8802.
78. [78] Elkins, C.A., Savage, D.C., Identification of genes encoding conjugated bile salt hydrolase and transport in Lactobacillus johnsonii 100-100. J. Bacteriol. 180:17 (1998), 4344–4349.
79. [79] Swinburn, B.A., Caterson, I., Seidell, J.C., James, W.P., Diet, nutrition and the prevention of excess weight gain and obesity. Public Health Nutr. 7:1A (2004 Feb), 123–146 Review. PubMed PMID: 14972057.
80. [80] Raoult, D., Obesity pandemics and the modification of digestive bacterial flora. Eur. J. Clin. Microbiol. Infect. Dis. 27:8 (2008), 631–634.
81. [81] Walsh, M.C., Gardiner, G.E., Hart, O.M., Lawlor, P.G., Daly, M., Lynch, B., Richert, B.T., Radcliffe, S., Giblin, L., Hill, C., Fitzgerald, G.F., Stanton, C., Ross, P., Predominance of a bacteriocin-producing Lactobacillus salivarius component of a five-strain probiotic in the porcine ileum and effects on host immune phenotype. FEMS Microbiol. Ecol. 64:2 (2008 May), 317–327.
82. [82] Christl, S.U., Scheppach, W., Metabolic consequences of total colectomy. Scand. J. Gastroenterol. Suppl. 222 (1997), 20–24 Review. PubMed PMID: 9145441.
83. [83] Raoult, D., Henrissat, B., Are stool samples suitable for studying the link between gut microbiota and obesity?. Eur. J. Epidemiol. 29:5 (2014 May), 307–309.
84. [84] Pot, B., Ludwig, W., Kersters, K., Schleifer, K.H., de Vuyst, L., Vandamme, E.J., (eds.) Taxonomy of Lactic Acid Bacteria, 1994, Chapman & Hall, 13–89.
85. [85] Hammes, W.P., Vogel, R.F., Wood, B.J.B., Holzapfel, W.H., (eds.) The Genus Lactobacillus, 1995, Blackie Academic & Professional, 19–54.
86. [86] Rohr, Lukas M., Teuber, Michael, Meile, Leo, Phosphoketolase, a neglected enzyme of microbial carbohydrate metabolism. CHIMIA Int. J. Chem. 56:6 (2002), 270–273.
87. [87] Nigatu, A., Evaluation of numerical analyses of RAPD and API 50 CH patterns to differentiate Lactobacillus plantarum, Lact. fermentum, Lact. rhamnosus, Lact. sake, Lact. parabuchneri, Lact. gallinarum, Lact. casei, Weissella minor and related taxa isolated from kocho and tef. J. Appl. Microbiol. 89:6 (2000 Dec), 969–978.
88. [88] Drissi, F., Merhej, V., Angelakis, E., El Kaoutari, A., Carriere, F., Henrissat, B., et al. Comparative genomics analysis of Lactobacillus species associated with weight gain or weight protection. Nutr. Diabetes, 4, 2014 e109.
89. [89] Fitzsimons, A., Hols, P., Jore, J., Leer, R.J., O'Connell, M., Delcour, J., Development of an amylolytic Lactobacillus plantarum silage strain expressing the Lactobacillus amylovorus alpha-amylase gene. Appl. Environ. Microbiol. 60:10 (1994 Oct), 3529–3535.
90. [90] Makarova, K., Slesarev, A., Wolf, Y., Sorokin, A., Mirkin, B., Koonin, E., et al. Comparative genomics of the lactic acid bacteria. Proc. Natl. Acad. Sci. U. S. A. 103:42 (2006 Oct 17), 15611–15616.
91. [91] Douillard, F.P., Ribbera, A., Kant, R., Pietila, T.E., Jarvinen, H.M., Messing, M., et al. Comparative genomic and functional analysis of 100 Lactobacillus rhamnosus strains and their comparison with strain GG. PLoS Genet., 9(8), 2013 Aug, e1003683.
92. [92] Molenaar, D., Bringel, F., Schuren, F.H., de Vos, W.M., Siezen, R.J., Kleerebezem, M., Exploring Lactobacillus plantarum genome diversity by using microarrays. J. Bacteriol. 187:17 (2005 Sep), 6119–6127.
93. [93] Kang, J.H., Yun, S.I., Park, M.H., Park, J.H., Jeong, S.Y., Park, H.O., Anti-obesity effect of Lactobacillus gasseri BNR17 in high-sucrose diet-induced obese mice. PLoS One, 8(1), 2013, e54617.
94. [94] Hamad, E.M., Sato, M., Uzu, K., Yoshida, T., Higashi, S., Kawakami, H., et al. Milk fermented by Lactobacillus gasseri SBT2055 influences adipocyte size via inhibition of dietary fat absorption in Zucker rats. Br. J. Nutr. 101:5 (2009 Mar), 716–724.
95. [95] Zhang, Yong, et al. The antioxidative effects of probiotic Lactobacillus casei Zhang on the hyperlipidemic rats. Eur. Food Res. Technol. 231:1 (2010), 151–158.
96. [96] De Boever, P., Wouters, R., Verschaeve, L., Berckmans, P., Schoeters, G., Verstraete, W., Protective effect of the bile salt hydrolase-active Lactobacillus reuteri against bile salt cytotoxicity. Appl. Microbiol. Biotechnol. 53:6 (2000 Jun), 709–714.
97. [97] McAuliffe, O., Cano, R.J., Klaenhammer, T.R., Genetic analysis of two bile salt hydrolase activities in Lactobacillus acidophilus NCFM. Appl. Environ. Microbiol. 71:8 (2005 Aug), 4925–4929.
98. [98] Fernando, Warnakulasuriya, et al. Enhancement of short chain fatty acid formation by pure cultures of probiotics on rice fibre. Int. J. Food Sci. Technol. 45:4 (2010), 690–696.
99. [99] Fernandes, J., Su, W., Rahat-Rozenbloom, S., Wolever, T.M., Comelli, E.M., Adiposity, gut microbiota and faecal short chain fatty acids are linked in adult humans. Nutr. Diabetes, 4, 2014 Jun 30 e121.
100. [100] Schwiertz, A., Taras, D., Schäfer, K., Beijer, S., Bos, N.A., Donus, C., et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity 18 (2010), 190–195.
101. [101] Teixeira, T.F.S., Grzeskowiak, L., Franceschini, S.C.C., Bressan, J., Ferreira, C.L.L.F., Peluzio, M.C.G., Higher level of faecal SCFA in women correlates with metabolic syndrome risk factors. Br. J. Nutr. 109 (2013), 914–919.
102. [102] Amarù, D.L., Field, C.J., Conjugated linoleic acid decreases mcf-7 human breast cancer cell growth and insulin-like growth factor-1 receptor levels. Lipids 44:5 (2009 May), 449–458.
103. [103] Lehnen, T.E., da Silva, M.R., Camacho, A., Marcadenti, A., Lehnen, A.M., A review on effects of conjugated linoleic fatty acid (CLA) upon body composition and energetic metabolism. J. Int. Soc. Sports Nutr., 12, 2015 Sep 17, 36.
104. [104] Zeng, Z., Lin, J., Gong, D., Identification of lactic acid bacterial strains with high conjugated linoleic acid-producing ability from natural sauerkraut fermentations. J. Food Sci. 74:4 (2009 May), M154–M158.
105. [105] O'Shea, E.F., Cotter, P.D., Stanton, C., Ross, R.P., Hill, C., Production of bioactive substances by intestinal bacteria as a basis for explaining probiotic mechanisms: bacteriocins and conjugated linoleic acid. Int. J. Food Microbiol. 152:3 (2012 Jan 16), 189–205.
106. [106] Kang, K., Liu, W., Albright, K.J., Park, Y., Pariza, M.W., trans-10,cis-12 CLA inhibits differentiation of 3T3-L1 adipocytes and decreases PPAR gamma expression. Biochem. Biophys. Res. Commun. 303:3 (2003 Apr 11), 795–799.
107. [107] Gaullier, J.M., Halse, J., Høivik, H.O., Høye, K., Syvertsen, C., Nurminiemi, M., Hassfeld, C., Einerhand, A., O'Shea, M., Gudmundsen, O., Six months supplementation with conjugated linoleic acid induces regional-specific fat mass decreases in overweight and obese. Br. J. Nutr. 97:3 (2007 Mar), 550–560.
108. [108] Wang, H., Fewer, D.P., Holm, L., Rouhiainen, L., Sivonen, K., Atlas of nonribosomal peptide and polyketide biosynthetic pathways reveals common occurrence of nonmodular enzymes. Proc. Natl. Acad. Sci. U. S. A. 111:25 (2014 Jun 24), 9259–9264.
109. [109] Arqués, J.L., Rodríguez, E., Langa, S., Landete, J.M., Medina, M., Antimicrobial activity of lactic acid bacteria in dairy products and gut: effect on pathogens. BioMed Res. Int., 2015, 2015, 584183.
110. [110] Gotteland, M., Andrews, M., Toledo, M., Muñoz, L., Caceres, P., Anziani, A., Wittig, E., Speisky, H., Salazar, G., Modulation of Helicobacter pylori colonization with cranberry juice and Lactobacillus johnsonii La1 in children. Nutrition 24:5 (2008 May), 421–426.
111. [111] Casey, P.G., Gardiner, G.E., Casey, G., Bradshaw, B., Lawlor, P.G., Lynch, P.B., Leonard, F.C., Stanton, C., Ross, R.P., Fitzgerald, G.F., Hill, C., A five-strain probiotic combination reduces pathogen shedding and alleviates disease signs in pigs challenged with Salmonella enterica Serovar Typhimurium. Appl. Environ. Microbiol. 73 (2007), 1858–1863.
112. [112] Cotter, P.D., Hill, C., Ross, R.P., Bacteriocins: developing innate immunity for food. Nat. Rev. Microbiol. 3:10 (2005 Oct), 777–788.
113. [113] Cotter, P.D., Ross, R.P., Hill, C., Bacteriocins - a viable alternative to antibiotics?. Nat. Rev. Microbiol. 11:2 (2013 Feb), 95–105.
114. [114] Flynn, S., van Sinderen, D., Thornton, G.M., et al. Characterization of the genetic locus responsible for the production of ABP-118, a novel bacteriocin produced by the probiotic bacterium Lactobacillus salivarius subsp. salivarius UCC118. Microbiology, 148, 2002, 973e84.
115. [115] Corr, S.C., Li, Y., Riedel, C.U., O'Toole, P.W., Hill, C., Gahan, C.G., Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc. Natl. Acad. Sci. U. S. A. 104:18 (2007 May 1), 7617–7621.
116. [116] Klaenhammer, T.R., Genetics of bacteriocins produced by lactic acid bacteria. FEMS Microbiol. Rev. 12 (1993), 39–85.
117. [117] Jack, R.W., Tagg, J.R., Ray, B., Bacteriocins of gram-positive bacteria. Microbiol. Rev. 59 (1995), 171–200 25.
118. [118] Cintas, L.M., et al. Review: bacteriocins of lactic acid bacteria. Food Sci. Technol. Int. 7:4 (2001), 281–305.
119. [119] Riley, Margaret A., Wertz, John E., Bacteriocins: evolution, ecology, and application. Annu. Rev. Microbiol. 56:1 (2002), 117–137.
120. [120] Silva, M., Jacobus, N.V., Deneke, C., Gorbach, S.L., Antimicrobial substance from a human Lactobacillus strain. Antimicrob. Agents Chemother. 31:8 (1987 Aug), 1231–1233.
121. [121] Svetoch, E.A., Eruslanov, B.V., Levchuk, V.P., Perelygin, V.V., Mitsevich, E.V., et al. Isolation of Lactobacillus salivarius 1077 (NRRL B-50053) and characterization of its bacteriocin, including the antimicrobial activity spectrum. Appl. Environ. Microbiol. 77 (2011), 2749–2754.
122. [122] Zouhir, A., Hammami, R., Fliss, I., Hamida, J.B., A new structure-based classification of gram-positive bacteriocins. Protein J. 29:6 (2010 Aug), 432–439.
123. [123] Ennahar, S., Sashihara, T., Sonomoto, K., Ishizaki, A., Class IIa bacteriocins: biosynthesis, structure and activity. FEMS Microbiol. Rev. 24:1 (2000 Jan), 85–106.
124. [124] Drissi, F., Buffet, S., Raoult, D., Merhej, V., Common occurrence of antibacterial agents in human intestinal microbiota. Front. Microbiol., 6, 2015 May 7, 441.
125. [125] Alakomi, H.L., Skyttä, E., Saarela, M., Mattila-Sandholm, T., Latva-Kala, K., Helander, I.M., Lactic acid permeabilizes gram-negative bacteria by disrupting the outer membrane. Appl. Environ. Microbiol. 66 (2000), 2001–2005.
126. [126] Gänzle, M.G., Reutericyclin: biological activity, mode of action, and potential applications. Appl. Microbiol. Biotechnol. 64:3 (2004 Apr), 326–332.
127. [127] Spinler, J.K., Taweechotipatr, M., Rognerud, C.L., Ou, C.N., Tumwasorn, S., Versalovic, J., Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens. Anaerobe 14:3 (2008 Jun), 166–171.
128. [128] Pascual, L.M., Daniele, M.B., Giordano, W., Pajaro, M.C., Barberis, I.L., Purification and partial characterization of novel bacteriocin L23 produced by Lactobacillus fermentum L23. Curr. Microbiol. 56:4 (2008 Apr), 397–402.
129. [129] De, V.L., Avonts, L., Neysens, P., Hoste, B., Vancanneyt, M., Swings, J., et al. The lactobin A and amylovorin L471 encoding genes are identical, and their distribution seems to be restricted to the species Lactobacillus amylovorus that is of interest for cereal fermentations. Int. J. Food Microbiol. 90:1 (2004 Jan 1), 93–106.
130. [130] Chen, Y.S., Wang, Y.C., Chow, Y.S., Yanagida, F., Liao, C.C., Chiu, C.M., Purification and characterization of plantaricin Y, a novel bacteriocin produced by Lactobacillus plantarum 510. Arch. Microbiol. 196:3 (2014 Mar), 193–199.
131. [131] Sand, S.L., Nissen-Meyer, J., Sand, O., Haug, T.M., Plantaricin, A., A cationic peptide produced by Lactobacillus plantarum, permeabilizes eukaryotic cell membranes by a mechanism dependent on negative surface charge linked to glycosylated membrane proteins. Biochim. Biophys. Acta 1828:2 (2013 Feb), 249–259.
132. [132] Kawai, Y., Kemperman, R., Kok, J., Saito, T., The circular bacteriocins gassericin A and circularin A. Curr. Protein Pept. Sci. 5:5 (2004 Oct), 393–398.
133. [133] Ryan, M.P., Ross, R.P., Hill, C., Strategy for manipulation of cheese flora using combinations of lacticin 3147-producing and -resistant cultures. Appl. Environ. Microbiol. 67 (2001), 2699–2704.
134. [134] Kommineni, S., Bretl, D.J., Lam, V., Chakraborty, R., Hayward, M., Simpson, P., Cao, Y., Bousounis, P., Kristich, C.J., Salzman, N.H., Bacteriocin production augments niche competition by enterococci in the mammalian gastrointestinal tract. Nature 526:7575 (2015 Oct 29), 719–722.
135. [135] Abee, T., Pore-forming bacteriocins of gram-positive bacteria and self-protection mechanisms of producer organisms. FEMS Microbiol. Lett., 129, 1995, 1e10.
136. [136] Murphy, E.F., Cotter, P.D., Hogan, A., O'Sullivan, O., Joyce, A., Fouhy, F., Clarke, S.F., Marques, T.M., O'Toole, P.W., Stanton, C., Quigley, E.M., Daly, C., Ross, P.R., O'Doherty, R.M., Shanahan, F., Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity. Gut 62:2 (2013 Feb), 220–226.
137. [137] Montalban-Lopez, M., Sanchez-Hidalgo, M., Valdivia, E., Martínez-Bueno, M., Maqueda, M., Are bacteriocins underexploited? Novel applications for old antimicrobials. Curr. Pharm. Biotechnol. 12:8 (2011 Aug), 1205–1220.
138. [138] Kirkup, B.C. Jr., Bacteriocins as oral and gastrointestinal antibiotics: theoretical considerations, applied research, and practical applications. Curr. Med. Chem. 13:27 (2006), 3335–3350.
139. [139] Lohans, C.T., Vederas, J.C., Development of class IIa bacteriocins as therapeutic agents. Int. J. Microbiol., 2012, 2012, 386410.
140. [140] Diep, D.B., Axelsson, L., Grefsli, C., Nes, I.F., The synthesis of the bacteriocin sakacin A is 485 a temperature-sensitive process regulated by a pheromone peptide through a three-component regulatory system. Microbiology 146:Pt 9 (2000), 2155–2160.
141. [141] Todorov, S.D., Dicks, L.M.T., Comparison of two methods for purification of plantaricin ST31, a bacteriocin produced by Lactobacillus plantarum ST31. Enz. Microbiol. Technol. 36 (2004), 318–326.
142. [142] Tome, E., Pereira, V.L., Lopes, C.I., Gibbs, P.A., Teixera, C., ‘In vitro’ tests of suitability of bacteriocin - producing lactic acid bacteria, as potential biopreservation cultures in vacuum – packaged cold – smoked Salmon. Food Control 19 (2008), 535–543.
143. [143] Agregán, R., Alonso, E., Torrado, A., Pérez, N., A review on some important factors affecting bacteriocin production by lactococci, lactobacilli and pediococci. Curr. Biochem. Eng. 1 (2014), 9–24.
144. [144] Wannun, P., Piwat, S., Teanpaisan, R., Purification, characterization, and optimum conditions of fermencin SD11, a bacteriocin produced by human orally Lactobacillus fermentum SD11. Appl. Biochem. Biotechnol. J. Appl. Microbiol. 91:2001 (2016 Feb 18), 636–645.
145. [145] Straight, P.D., Fischbach, M.A., Walsh, C.T., Rudner, D.Z., Kolter, R., A singular enzymatic megacomplex from Bacillus subtilis. Proc. Natl. Acad. Sci. U. S. A. 104:1 (2007 Jan 2), 305–310.
146. [146] Toh, M., Moffitt, M.C., Henrichsen, L., Raftery, M., Barrow, K., Cox, J.M., et al. Cereulide, the emetic toxin of Bacillus cereus, is putatively a product of nonribosomal peptide synthesis. J. Appl. Microbiol. 97:5 (2004), 992–1000.
147. [147] Siezen, R.J., Starrenburg, M.J., Boekhorst, J., Renckens, B., Molenaar, D., van Hylckama Vlieg, J.E., Genome-scale genotype-phenotype matching of two Lactococcus lactis isolates from plants identifies mechanisms of adaptation to the plant niche. Appl. Environ. Microbiol. 74:2 (2008 Jan), 424–436.
148. [148] Challis, G.L., Naismith, J.H., Structural aspects of non-ribosomal peptide biosynthesis. Curr. Opin. Struct. Biol. 14:6 (2004 Dec), 748–756.
149. [149] Mootz, H.D., Schwarzer, D., Marahiel, M.A., Ways of assembling complex natural products on modular nonribosomal peptide synthetases. ChemBioChem 3 (2002), 490–504.
150. [150] Felnagle, E.A., Jackson, E.E., Chan, Y.A., Podevels, A.M., Berti, A.D., McMahon, M.D., Thomas, M.G., Nonribosomal peptide synthetases involved in the production of medically relevant natural products. Mol. Pharm. 5:2 (2008 Mar-Apr), 191–211.
151. [151] Kleerebezem, M., Boekhorst, J., van, K.R., Molenaar, D., Kuipers, O.P., Leer, R., et al. Complete genome sequence of Lactobacillus plantarum WCFS1. Proc. Natl. Acad. Sci. U. S. A. 100:4 (2003 Feb 18), 1990–1995.
152. [152] Agustina, R., Bovee-Oudenhoven, I.M., Lukito, W., Fahmida, U., van de Rest, O., Zimmermann, M.B., et al. Probiotics Lactobacillus reuteri DSM 17938 and Lactobacillus casei CRL 431 modestly increase growth, but not iron and zinc status, among Indonesian children aged 1-6 years. J. Nutr. 143:7 (2013 Jul), 1184–1193.
153. [153] Khan, M., Raoult, D., Richet, H., Lepidi, H., La, S.B., Growth-promoting effects of single-dose intragastrically administered probiotics in chickens. Br. Poult. Sci. 48:6 (2007 Dec), 732–735.
154. [154] Wang, X., Yang, F., Liu, C., Zhou, H., Wu, G., Qiao, S., et al. Dietary supplementation with the probiotic Lactobacillus fermentum I5007 and the antibiotic aureomycin differentially affects the small intestinal proteomes of weanling piglets. J. Nutr. 142:1 (2012 Jan), 7–13.
155. [155] Cruywagen, C.W., Jordaan, I., Venter, L., Effect of Lactobacillus acidophilus supplementation of milk replacer on preweaning performance of calves. J. Dairy Sci. 79:3 (1996 Mar), 483–486.
156. [156] Villena, J., Racedo, S., Aguero, G., Bru, E., Medina, M., Alvarez, S., Lactobacillus casei improves resistance to pneumococcal respiratory infection in malnourished mice. J. Nutr. 135:6 (2005 Jun), 1462–1469.
157. [157] Lan, P.T., Binh, L.T., Benno, Y., Impact of two probiotic Lactobacillus strains feeding on fecal lactobacilli and weight gains in chicken. J. Gen. Appl. Microbiol. 49:1 (2003 Feb), 29–36.
158. [158] Vendt, N., Grunberg, H., Tuure, T., Malminiemi, O., Wuolijoki, E., Tillmann, V., et al. Growth during the first 6 months of life in infants using formula enriched with Lactobacillus rhamnosus GG: double-blind, randomized trial. J. Hum. Nutr. Diet. 19:1 (2006 Feb), 51–58.
159. [159] Kang, J.H., Yun, S.I., Park, H.O., Effects of Lactobacillus gasseri BNR17 on body weight and adipose tissue mass in diet-induced overweight rats. J. Microbiol. 48:5 (2010 Oct), 712–714.
160. [160] Jung, S.P., Lee, K.M., Kang, J.H., Yun, S.I., Park, H.O., Moon, Y., et al. Effect of Lactobacillus gasseri BNR17 on overweight and obese adults: a randomized, double-blind clinical trial. Korean J. Fam. Med. 34:2 (2013 Mar), 80–89.
161. [161] Karlsson, C.L., Molin, G., Fak, F., Johansson Hagslatt, M.L., Jakesevic, M., Hakansson, A., et al. Effects on weight gain and gut microbiota in rats given bacterial supplements and a high-energy-dense diet from fetal life through to 6 months of age. Br. J. Nutr. 106:6 (2011 Sep), 887–895.
162. [162] Takemura, N., Okubo, T., Sonoyama, K., Lactobacillus plantarum strain no. 14 reduces adipocyte size in mice fed high-fat diet. Exp. Biol. Med. (Maywood) 235:7 (2010 Jul), 849–856.
163. [163] Sanchez, M., Darimont, C., Drapeau, V., Emady-Azar, S., Lepage, M., Rezzonico, E., et al. Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and women. Br. J. Nutr., 2013 Dec 3, 1–13.
164. [164] Tanida, M., Shen, J., Maeda, K., Horii, Y., Yamano, T., Fukushima, Y., et al. High-fat diet-induced obesity is attenuated by probiotic strain Lactobacillus paracasei ST11 (NCC2461) in rats. Obes. Res. Clin. Pract. 2:3 (2008 Sep), I–II.
165. [165] Sousa, R., Halper, J., Zhang, J., Lewis, S.J., Li, W.I., Effect of Lactobacillus acidophilus supernatants on body weight and leptin expression in rats. BMC Complement Altern. Med., 8, 2008, 5.
166. [166] Kabuki, T., Saito, T., Kawai, Y., Uemura, J., Itoh, T., Production, purification and characterization of reutericin 6, a bacteriocin with lytic activity produced by Lactobacillus reuteri LA6. Int. J. Food Microbiol. 34:2 (1997 Feb), 145–156.
167. [167] Toba, T., Yoshioka, E., Itoh, T., Acidophilucin A, a new heat-labile bacteriocin produced by Lactobacillus acidophilus LAPT 1060. Lett. Appl. Microbiol. 12 (1991), 106–108.
168. [168] Barefoot, S.F., Klaenhammer, T.R., Detection and activity of lactacin B, a bacteriocin produced by Lactobacillus acidophilus. Appl. Environ. Microbiol. 45 (1983), 1808–1815 And Barefoot SF, Klaenhammer TR. Purification and characterization of the acidophilus bacteriocin lactacin B. Antimicrob. Agents Chemother. 1984 Sep;26(3):328–334.
169. [169] Han, Kyoung-Sik, Younghoon, Kim, Sae-Hun, Kim, Sejong, Oh, Characterization and purification of Acidocin 1B, a bacteriocin produced by Lactobacillus acidophilus GP1B. J. Microbiol. Biotechnol. 17:5 (2007), 774–783.
170. [170] Stern, N.J., Svetoch, E.A., Eruslanov, B.V., Perelygin, V.V., Mitsevich, E.V., Mitsevich, I.P., Pokhilenko, V.D., Levchuk, V.P., Svetoch, O.E., Seal, B.S., Isolation of a Lactobacillus salivarius strain and purification of its bacteriocin, which is inhibitory to Campylobacter jejuni in the chicken gastrointestinal system. Antimicrob. Agents Chemother. 50:9 (2006 Sep), 3111–3116.
171. [171] Barrett, E., Hayes, M., O'Connor, P., Gardiner, G., Fitzgerald, G.F., Stanton, C., Ross, R.P., Hill, C., Salivaricin P, one of a family of two-component antilisterial bacteriocins produced by intestinal isolates of Lactobacillus salivarius. Appl. Environ. Microbiol. 73 (2007), 3719–3723.
172. [172] Toba, T., Yoshioka, E., Itoh, T., Potential of Lactobacillus gasseri isolated from infant faeces to produce bacteriocin. Lett. Appl. Microbiol. 12 (1991), 228–231.
173. [173] Kawai, Y., Saitoh, B., Takahashi, O., Kitazawa, H., Saito, T., Nakajima, H., Itoh, T., Primary amino acid and DNA sequences of gassericin T, a lactacin F-family bacteriocin produced by Lactobacillus gasseri SBT2055. Biosci. Biotechnol. Biochem. 64 (2000), 2201–2208.
174. [174] Zhu, W.M., Liu, W., Wu, D.Q., Isolation and characterization of a new bacteriocin from Lactobacillus gasseri KT7. J. Appl. Microbiol. 88 (2000), 877–886.
175. [175] Majhenic, A.C., Venema, K., Allison, G.E., Matijasic, B.B., Rogelj, I., Klaenhammer, T.R., DNA analysis of the genes encoding acidocin LF221 A and acidocin LF221 B, two bacteriocins produced by Lactobacillus gasseri LF221. Appl. Microbiol. Biotechnol. 63 (2004), 705–714.
176. [176] Bogovic-Matijasić, B., Rogelj, I., Nes, I.F., Holo, H., Isolation and characterization of two bacteriocins of Lactobacillus acidophilus LF221. Appl. Microbiol. Biotechnol. 49:5 (1998 May), 606–612.
177. [177] Anderssen, E.L., Diep, D.B., Nes, I.F., Eijsink, V.G., Nissen-Meyer, J., Antagonistic activity of Lactobacillus plantarum C11: two new two-peptide bacteriocins, plantaricins EF and JK, and the induction factor plantaricin A. Appl. Environ. Microbiol. 64:6 (1998 Jun), 2269–2272.
178. [178] Hata, T., Tanaka, R., Ohmomo, S., Isolation and characterization of plantaricin ASM1: a new bacteriocin produced by Lactobacillus plantarum A-1. Int. J. Food Microbiol. 137:1 (2010 Jan 31), 94–99.
179. [179] Gong, H.S., Meng, X.C., Wang, H., Plantaricin MG active against gram-negative bacteria produced by Lactobacillus plantarum KLDS1.0391 isolated from “Jiaoke”, a traditional fermented cream from China. Food Control 21:1 (January 2010), 89–96.
180. [180] Dover, S.E., Aroutcheva, A.A., Faro, S., Chikindas, M.L., Safety study of an antimicrobial peptide lactocin 160, produced by the vaginal Lactobacillus rhamnosus. Infect. Dis. Obstet. Gynecol., 2007, 2007, 78248.